+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Rosacea Market and Competitive Landscape - 2022

  • PDF Icon

    Report

  • August 2022
  • Region: United States
  • Fore Pharma
  • ID: 5644728
The report US Rosacea Market and Competitive Landscape Highlights - 2022, provides comprehensive insights into Rosacea pipeline products, Rosacea epidemiology, Rosacea market valuations and forecast, Rosacea drugs sales and competitive landscape in the US.

The research is classified into seven sections - Rosacea treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Rosacea pipeline: Find out the products in clinical trials for the treatment of Rosacea by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Rosacea epidemiology: Find out the number of patients diagnosed (prevalence) with Rosacea in the US
  • Rosacea drugs: Identify key products marketed and prescribed for Rosacea in the US, including trade name, molecule name, and company
  • Rosacea drugs sales: Find out the sales revenues of Rosacea drugs in the US
  • Rosacea market valuations: Find out the market size for Rosacea drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027
  • Rosacea drugs market share: Find out the market shares for key Rosacea drugs in the US

Benefits of this Research:

The research helps executives to
  • Support monitoring and reporting national Rosacea market analysis and sales trends
  • Track competitor drugs sales and market share in the US Rosacea market
  • Track competitive developments in Rosacea market and present key issues and learnings
  • Synthesize insights for Rosacea market and products to drive business performance
  • Answer key business questions about the Rosacea market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Rosacea products
  • Supports decision making in R&D to long term marketing strategies

Table of Contents

1) Rosacea Treatments
2) Rosacea Pipeline
3) US Rosacea Epidemiology
4) Marketed Drugs for Rosacea in US
5) US Rosacea Market Size and Forecast
6) US Rosacea Products Sales and Forecast
7) US Rosacea Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables
1. Rosacea Phase 3 Clinical Trials, 2022
2. Rosacea Phase 2 Clinical Trials, 2022
3. Rosacea Phase 1 Clinical Trials, 2022
4. Rosacea Epidemiology, US, 2021 - 2027
5. Marketed Drugs for Rosacea, US, 2021
6. Rosacea Market Size and Forecast ($), US, 2019 - 2027
7. Rosacea Drugs Sales ($), US, 2019 - 2027

List of Figures
1. Rosacea Epidemiology, US, 2021 - 2027
2. Rosacea Market Size and Forecast ($), US, 2019 - 2027
3. Rosacea Drugs Market Share (%), US, 2021